文献速递小儿眼科与斜弱视眼底病与葡萄膜炎

早产儿视网膜病变儿童斜视累积发病率

Incidence of Strabismus in Children With Retinopathy of Prematurity.
PubMed 文献 · Am J Ophthalmol · 2026-04-29

该回顾性队列研究纳入27720例≤18岁ROP患儿,其中973例接受治疗、26747例未治疗。Kaplan-Meier分析显示治疗组5年斜视累积发病率34.78%,未治疗组22.14%;治疗暴露与斜视风险独立相关(aHR=1.58),弱视(aHR=2.58)和眼球震颤(aHR=1.76)亦为独立危险因素。

要点

  • ROP患儿中治疗组5年斜视累积发病率为34.78%,高于未治疗组的22.14%。
  • 内斜视为最常见亚型,治疗组和未治疗组分别占22.35%和11.87%。
  • ROP治疗暴露、弱视和眼球震颤均与斜视风险独立相关。

核心结论

  • ROP患儿后续发生斜视的风险增加,接受治疗的患儿累积发病率更高。

研究设计与样本

  • 回顾性队列研究,纳入≤18岁诊断为ROP的儿童和青少年27720例,其中治疗组973例、未治疗组26747例。
  • 治疗定义为接受激光光凝和/或玻璃体腔抗VEGF注射,未治疗定义为无上述干预记录。

主要发现

  • 治疗组5年斜视累积发病率为34.78%,未治疗组为22.14%。
  • 内斜视为最常见亚型,治疗组发生率为22.35%,未治疗组为11.87%。
  • 治疗暴露与斜视风险增加独立相关(aHR=1.58;95%CI=1.29-1.95;P<.001)。
  • 弱视(aHR=2.58;95%CI=2.25-2.96;P<.001)和眼球震颤(aHR=1.76;95%CI=1.48-2.10;P<.001)亦与斜视风险增加独立相关。

临床怎么用

  • 对ROP患儿,尤其是接受过激光或抗VEGF治疗的患儿,应加强斜视筛查与随访。
  • 合并弱视或眼球震颤的ROP患儿斜视风险更高,需重点关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To estimate the cumulative incidence of strabismus among children diagnosed with retinopathy of prematurity (ROP). DESIGN: Retrospective cohort study. METHODS: Participants were children and adolescents aged ≤18 years with a diagnosis of ROP, with or without treatment exposure. We defined treated ROP as receipt of laser photocoagulation and/or intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection, whereas untreated ROP had no record of either intervention. We estimated the cumulative incidence of strabismus at 1, 3, and 5 years after ROP diagnosis using Kaplan-Meier analysis. We used Cox proportional hazards models to calculate adjusted hazard ratios (aHR) and 95% confidence intervals (CI), adjusting for demographic variables and ocular comorbidities. The main outcome measure was development of strabismus following ROP diagnosis. RESULTS: The cohort included 27,720 ROP patients: 973 were treated, and 26,747 were untreated. cumulative incidence of strabismus was consistently higher among treated patients. At 5 years, cumulative incidence was 34.78% in treated patients compared with 22.14% in untreated patients, with esodeviations as the most common subtype, occurring in 22.35% of treated patients and 11.87% of untreated patients. Treatment exposure was independently associated with an increased hazard of strabismus (aHR = 1.58; 95% CI = 1.29-1.95; P < .001). Amblyopia (aHR = 2.58; 95% CI = 2.25-2.96; P < .001) and nystagmus (aHR = 1.76; 95% CI = 1.48-2.10; P < .001) were also independently associated with increased hazard. CONCLUSIONS: ROP confers an increased hazard of developing subsequent strabismus, with higher cumulative incidence among children who underwent treatment for ROP.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Almobayed A, Dihan Q, Cohen AK, et al. Incidence of Strabismus in Children With Retinopathy of Prematurity. Am J Ophthalmol. 2026. PMID: 42067049. doi:10.1016/j.ajo.2026.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。